Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
![Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy](https://www.mbrl.ae/o/mbrl-theme/images/site-assets/generic/no-book-image.png)
Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy
by
Sandner, Peter
, Nordlohne, Johannes
, Seifert, Roland
, Hüser, Jörg
, Mathar, Ilka
, Vakalopoulos, Alexandros
, Hartmann, Elke
, Krishnan, Shalini Murali
, Dietz, Lisa
, Haning, Petra
in
Blood flow
/ Collagen
/ Creatine
/ Creatine kinase
/ Cyclic GMP
/ Cytokines
/ Diaphragm (Anatomy)
/ duchenne muscular dystrophy
/ Duchenne's muscular dystrophy
/ Efficiency
/ Enzymes
/ Fibrosis
/ Food
/ Gene expression
/ Grip strength
/ Immune system
/ Inflammation
/ Ischemia
/ Kinases
/ mdx/mTRG2 mice
/ Muscle function
/ Muscles
/ Muscular dystrophy
/ Musculoskeletal system
/ Mutation
/ Nitric oxide
/ Proteins
/ Running
/ sGC stimulator
/ Skeletal muscle
/ skeletal muscle damage
/ skeletal muscle function
/ Stimulators
/ Therapeutic applications
/ Wheel running
2021
![Hey, we have placed the reservation for you!](https://www.mbrl.ae/o/mbrl-theme/images/site-assets/illustrations/modal-success.png)
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
![Oops! Something went wrong.](https://www.mbrl.ae/o/mbrl-theme/images/site-assets/illustrations/modal-fail.png)
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
![](https://www.mbrl.ae/o/mbrl-theme/images/site-assets/generic/no-book-image.png)
Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy
by
Sandner, Peter
, Nordlohne, Johannes
, Seifert, Roland
, Hüser, Jörg
, Mathar, Ilka
, Vakalopoulos, Alexandros
, Hartmann, Elke
, Krishnan, Shalini Murali
, Dietz, Lisa
, Haning, Petra
in
Blood flow
/ Collagen
/ Creatine
/ Creatine kinase
/ Cyclic GMP
/ Cytokines
/ Diaphragm (Anatomy)
/ duchenne muscular dystrophy
/ Duchenne's muscular dystrophy
/ Efficiency
/ Enzymes
/ Fibrosis
/ Food
/ Gene expression
/ Grip strength
/ Immune system
/ Inflammation
/ Ischemia
/ Kinases
/ mdx/mTRG2 mice
/ Muscle function
/ Muscles
/ Muscular dystrophy
/ Musculoskeletal system
/ Mutation
/ Nitric oxide
/ Proteins
/ Running
/ sGC stimulator
/ Skeletal muscle
/ skeletal muscle damage
/ skeletal muscle function
/ Stimulators
/ Therapeutic applications
/ Wheel running
2021
![Oops! Something went wrong.](https://www.mbrl.ae/o/mbrl-theme/images/site-assets/illustrations/modal-fail.png)
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
![Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy](https://www.mbrl.ae/o/mbrl-theme/images/site-assets/generic/no-book-image.png)
Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy
by
Sandner, Peter
, Nordlohne, Johannes
, Seifert, Roland
, Hüser, Jörg
, Mathar, Ilka
, Vakalopoulos, Alexandros
, Hartmann, Elke
, Krishnan, Shalini Murali
, Dietz, Lisa
, Haning, Petra
in
Blood flow
/ Collagen
/ Creatine
/ Creatine kinase
/ Cyclic GMP
/ Cytokines
/ Diaphragm (Anatomy)
/ duchenne muscular dystrophy
/ Duchenne's muscular dystrophy
/ Efficiency
/ Enzymes
/ Fibrosis
/ Food
/ Gene expression
/ Grip strength
/ Immune system
/ Inflammation
/ Ischemia
/ Kinases
/ mdx/mTRG2 mice
/ Muscle function
/ Muscles
/ Muscular dystrophy
/ Musculoskeletal system
/ Mutation
/ Nitric oxide
/ Proteins
/ Running
/ sGC stimulator
/ Skeletal muscle
/ skeletal muscle damage
/ skeletal muscle function
/ Stimulators
/ Therapeutic applications
/ Wheel running
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
![We have requested the book for you!](https://www.mbrl.ae/o/mbrl-theme/images/site-assets/illustrations/modal-success.png)
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
![Oops! Something went wrong.](https://www.mbrl.ae/o/mbrl-theme/images/site-assets/illustrations/modal-fail.png)
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy
![Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy](https://syndetics.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=MBRL&type=mbrl)
Journal Article
Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy
2021
Request now
and choose the collection method
Overview
Duchenne muscular dystrophy (DMD) is a severe and progressive muscle wasting disorder, affecting one in 3500 to 5000 boys worldwide. The NO-sGC-cGMP pathway plays an important role in skeletal muscle function, primarily by improving blood flow and oxygen supply to the muscles during exercise. In fact, PDE5 inhibitors have previously been investigated as a potential therapy for DMD, however, a large-scale Phase III clinical trial did not meet its primary endpoint. Since the efficacy of PDE5i is dependent on sufficient endogenous NO production, which might be impaired in DMD, we investigated if NO-independent sGC stimulators, could have therapeutic benefits in a mouse model of DMD. Male mdx/mTRG2 mice aged six weeks were given food supplemented with the sGC stimulator, BAY-747 (150 mg/kg of food) or food alone (untreated) ad libitum for 16 weeks. Untreated C57BL6/J mice were used as wild type (WT) controls. Assessments of the four-limb hang, grip strength, running wheel and serum creatine kinase (CK) levels showed that mdx/mTRG2 mice had significantly reduced skeletal muscle function and severe muscle damage compared to WT mice. Treatment with BAY-747 improved grip strength and running speed, and these mice also had reduced CK levels compared to untreated mdx/mTRG2 mice. We also observed increased inflammation and fibrosis in the skeletal muscle of mdx/mTRG2 mice compared to WT. While gene expression of pro-inflammatory cytokines and some pro-fibrotic markers in the skeletal muscle was reduced following BAY-747 treatment, there was no reduction in infiltration of myeloid immune cells nor collagen deposition. In conclusion, treatment with BAY-747 significantly improves several functional and pathological parameters of the skeletal muscle in mdx/mTRG2 mice. However, the effect size was moderate and therefore, more studies are needed to fully understand the potential treatment benefit of sGC stimulators in DMD.
This website uses cookies to ensure you get the best experience on our website.